SCHEMBL6992434

SCHEMBL6992434

Cc1ccc(NC(=N)N(CCc2ccccc2)c2ccc(C)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
CYP2C19 P33261 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
MAPT P10636 5/20 0.42
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
ALOX15 P16050 1/20 0.42
NFKB1 P19838 1/20 0.42
MAPK1 P28482 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
MCL1 Q07820 1/20 0.42
NPY5R Q15761 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
GAA P10253 1/20 0.41
ALOX12 P18054 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6299756 0.85 POLB (0.44) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL6298600 0.82 POLB (0.42) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL6298803 0.80 ALDH1A1 (0.41) ALDH1A1MAPTRAB9ASMN1; SMN2MAPK1
SCHEMBL6298823 0.77 MAPT (0.59) ALDH1A1MAPTMAPK1MEN1KMT2A
SCHEMBL6298817 0.76 ALDH1A1 (0.38) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL6579177 0.75 MAPT (0.36) ALDH1A1MAPTRAB9ASMN1; SMN2MAPK1
SCHEMBL10336593 0.74 RAB9A (0.46) ALDH1A1CYP2C19MAPTNPC1RAB9A
SCHEMBL4982717 0.73 LMNA (0.48) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL4097943 0.73 KMT2A (0.53) ALDH1A1MAPTNPC1RAB9AMEN1
SCHEMBL10336591 0.72 NPC1 (0.47) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2003525213-A 2003-08-26 JP claimed
EP-1202718-A2 SUBSTITUTED GUANIDINES FOR THE TREATMENT OF CANCER AND PAIN Kadmus Pharmaceuticals, Inc. (US) 2002-05-08 EP claimed
WO-2001007029-A2 SUBSTITUTED GUANIDINES AND THE USE THEREOF KADMUS PHARMACEUTICALS, INC. (US) 2001-02-01 WO claimed